Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors

Tumor-informed ctDNA analysis shows promise for MRD detection in patients with GCTs. With further study, ctDNA monitoring may be useful in clinical decision making. Larger prospective trials are planned to establish clinical utility.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2025-09-24
DOI
https://doi.org/10.1200/po-25-00176
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors

Adam Rock, Reuben Ben‐David, Rebecca Hassoun, Neeraja Tillu et al.
JCO Precision Oncology
Cancer Genomics and Diagnostics
article

Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors

Adam Rock, Reuben Ben‐David, Rebecca Hassoun, Neeraja Tillu, Cherry Au, John P. Sfakianos, Kevin Manage, Timothy A. Masterson, Clint Cary, Shruti Sharma, Minetta C. Liu, Punashi Dutta, George Laliotis, Jennifer King, Adam C. ElNaggar, Alex Chehrazi‐Raffle, Lawrence H. Einhorn, Nabil Adra, Jordan Rich, Shivaram Cumarasamy, Tanya Barauskas Dorff, Alan Tan, Mukti Patel
article en

Abstract

Tumor-informed ctDNA analysis shows promise for MRD detection in patients with GCTs. With further study, ctDNA monitoring may be useful in clinical decision making. Larger prospective trials are planned to establish clinical utility.

JCO Precision OncologyVol. 9(9)
Indiana University Health (US), Rush University Medical Center (US), City of Hope (US), Natera (United States) (US), Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University – Purdue University Indianapolis (US), Vanderbilt University Medical Center (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 68%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.